196 related articles for article (PubMed ID: 1356724)
1. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
Savina PM; Brouwer KL
Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
[TBL] [Abstract][Full Text] [Related]
2. Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat.
Brouwer KL
Drug Metab Dispos; 1993; 21(6):1129-33. PubMed ID: 7905395
[TBL] [Abstract][Full Text] [Related]
3. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.
Studenberg SD; Brouwer KL
J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
Brouwer KL; Jones JA
J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
[TBL] [Abstract][Full Text] [Related]
5. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
[TBL] [Abstract][Full Text] [Related]
7. In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition.
Turner KC; Brouwer KL
Drug Metab Dispos; 1997 Sep; 25(9):1017-21. PubMed ID: 9311615
[TBL] [Abstract][Full Text] [Related]
8. Glucuronidation and biliary excretion of acetaminophen in rats.
Hjelle JJ; Klaassen CD
J Pharmacol Exp Ther; 1984 Feb; 228(2):407-13. PubMed ID: 6694118
[TBL] [Abstract][Full Text] [Related]
9. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
[TBL] [Abstract][Full Text] [Related]
10. Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats.
Trumper L; Monasterolo LA; Elías MM
J Pharmacol Exp Ther; 1998 Feb; 284(2):606-10. PubMed ID: 9454804
[TBL] [Abstract][Full Text] [Related]
11. Hepatic disposition of acetaminophen and metabolites. Pharmacokinetic modeling, protein binding and subcellular distribution.
Studenberg SD; Brouwer KL
Biochem Pharmacol; 1993 Aug; 46(4):739-46. PubMed ID: 8363647
[TBL] [Abstract][Full Text] [Related]
12. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
Watkins JB
J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
[TBL] [Abstract][Full Text] [Related]
13. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
Gregus Z; Madhu C; Klaassen CD
Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
[TBL] [Abstract][Full Text] [Related]
14. Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin.
Watkins JB; Sherman SE
J Pharmacol Exp Ther; 1992 Mar; 260(3):1337-43. PubMed ID: 1545396
[TBL] [Abstract][Full Text] [Related]
15. Changes in pharmacokinetic profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either glycyrrhizin, silibinin or spironolactone in rat.
Xu R; Wang Q; Zhang J; Zang M; Liu X; Yang J
Xenobiotica; 2014 Jun; 44(6):541-6. PubMed ID: 24251357
[TBL] [Abstract][Full Text] [Related]
16. The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice.
Zamek-Gliszczynski MJ; Nezasa K; Tian X; Kalvass JC; Patel NJ; Raub TJ; Brouwer KL
Mol Pharmacol; 2006 Dec; 70(6):2127-33. PubMed ID: 16959944
[TBL] [Abstract][Full Text] [Related]
17. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
Hu J; Liu X; Xie L; Wang G; Liu H
Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
Chen C; Hennig GE; Manautou JE
Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
[TBL] [Abstract][Full Text] [Related]
20. Effect of taurine on biliary excretion and metabolism of acetaminophen in male hamsters.
Lee JY; Jung DW; Park HA; Kim SJ; Chung JH; Moon CK; Kim YC
Biol Pharm Bull; 2004 Nov; 27(11):1792-6. PubMed ID: 15516725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
